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CHAPTER I
INTRODUCTION
Declines in regional brain volume (Raz and Kennedy, 2009) and decreased cognitive
function (Horn and Donaldson, 1980) are hallmarks of normal aging. However, age-related
differences are not uniform. Patterns of decline vary between brain regions (Raz et al., 2010) as
well as affected cognitive functions (Horn and Donaldson, 1980; Lindenberger et al., 1993; Park,
2000). Further, there are individual differences in the magnitude of decline across the lifespan
(Raz, 2005; Raz and Kennedy, 2009). The lack of uniformity in brain aging suggests additional
mediating factors that modify regional and individual aging trajectories (Raz et al., 2004; Raz,
2005; Raz and Kennedy, 2009). The modifying factors are manifold and likely interact.
Compromised neuronal metabolism by cellular factors or systemic cardiovascular health
may differentiate age-sensitive neural and cognitive systems. Accumulation of non-heme iron in
the brain is one such cellular factor that disrupts metabolism via oxidative stress (Harman, 1956;
see Mills et al., 2010 and Bartzokis, 2011 for reviews). However, deleterious effects of iron in
healthy brain aging are poorly understood, and even less is known of their cognitive
consequences and interactions with cardiovascular health.

This uncertainty about true

cumulative effect of brain iron in healthy aging largely stems from the fact that change has been
inferred from cross-sectional studies that are incapable of estimating individual differences in
change and evaluating their mediators (Maxwell and Cole, 2007; Lindenberger et al., 2011; Raz
and Lindenberger, 2011).

In the first in vivo longitudinal study of brain iron, Walsh and

colleagues (2014) recently reported increase in subcortical iron content, but did not examine
individual differences or the influence of confounding age-related risk factors.

A need of

addressing these issues served as the main impetus for the series of studies presented here.
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Although interventions are not included in the present study, longitudinal assessment of iron
content in healthy aging brains may identify an early marker of later-life decline with possible
treatment (see Schenck and Zimmerman, 2004). Determination of injurious metabolic factors
will inform lifetime strategies to promote successful aging.
The present study is a longitudinal assessment of changes in and mutual influences of
regional iron content, regional brain volumes, systemic cardiovascular health, and cognitive
performance. The aims of this study are threefold. The first aim is to determine the longitudinal
change and, more importantly, variance in change of iron content across brain regions, and to
elucidate the relationship between iron content and regional brain shrinkage in healthy aging.
Second, I sought to investigate the role of sub-clinical increase in cardiovascular risk in agerelated iron accumulation and volumetric decline. The final aim was to evaluate the indirect
effects of aging on two age-sensitive cognitive domains—working memory and spatial
navigation—mediated by regional changes in volume and iron content.

Figure 1. A sketch of study aims and hypothesized relationships between age and the target
variables.

1.1 Iron as an Oxidative Stress Factor in Brain Aging
In biological systems, iron exists in two forms: heme and non-heme iron. Heme iron is in
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the core of the hemoglobin molecule and is thus present in the brain wherever blood flows or
accumulates (Tingey, 1938). Heme iron in circulating cerebral blood has no known deleterious
effects and is therefore not considered to contribute to neurodegeneration (Halliwell, 1992; Mills
et al., 2010). However, other sources of heme iron (i.e., cerebral microbleed or hemosedrin) are
less benign (see Loitfelder, Seiler, Schwingenschuh, and Schmidt, 2011 for a review). Whereas
the prevalence of cerebral microbleeds in healthy adults is relatively low (Yates et al., 2011; see
Loitfelder, Seiler, Schwingenschuh, and Schmidt, 2011 for a review), subcortical non-heme iron
appears to continuously accumulate across the lifespan (Daugherty and Raz, 2013). In contrast
to its heme form, excess free non-heme iron has been consistently identified as a correlate of
neurological pathology (see Bartzokis, 2011; Zecca et al., 2004; Lauffer, 1992 for reviews) and
may be a harbinger of impairment.
Intracellular non-heme iron is a critical oxidizing agent in normal metabolism, but in
excess promotes oxidative stress and thus is a potential factor in cellular deterioration (see Mills
et al., 2010 for a review).

Healthy neurons store non-heme iron for lipid peroxidation,

mitochondrial ATP generation, and DNA replication (see Mills et al., 2010 for a review).
Oligodendrocytes depend on bioavailability of iron for myelination, the precise mechanism of
which is unclear, but is likely due to iron as a cofactor necessary for energy production
(Todorich et al., 2009). However, iron-catalyzed reactions commonly produce reactive oxygen
species (OH-; hydroxyl anions) that cause oxidative stress. Thereby an excess of unregulated
soluble non-heme iron can become toxic (see Zecca et al., 2004; Mills et al., 2010 for reviews).
Cellular non-heme iron is normally bound to transferrin (Bloch et al., 1985; Lauffer, 1992) or
sequestered in ferritin (Diezel, 1955; Fisher et al., 2006), which appears to control the potential
deleterious effects. In a healthy neuron, upwards of 90% of non-heme iron is sequestered in
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ferritin (Jara et al., 2006), where it remains until mitochondria signal solubilization for
immediate metabolism (Chrichton and Ward, 1992).
Intracellular non-heme iron concentration depends on metabolic need (see Mills et al.,
2010 for a review). Outside of ferritin sequestration, metabolically necessary soluble non-heme
iron (mostly Fe2+) is represented as the labile pool (approximately 1 µM) that is bound to amino
acids (Lauffer, 1992), ATP (Cabantchik et al., 2002) and metallochaperones (Mills et al., 2010).
During metabolism, neurons express a unique combination of transport proteins that strictly
regulate soluble non-heme iron (Dong et al., 2008; Gunshin et al., 1997; Moos et al., 2007; see
Mills et al., 2010 for a review). The transport proteins bind and ferry non-heme iron from
ferritin sequestration and in the labile pool until the iron is required, neutralizing the iron and
thereby limiting the rate of oxidative stress (Dong et al., 2008; Gunshin et al., 1997; Moos et al.,
2007; see Mills et al., 2010 for a review). The delicate intracellular equilibrium depends upon
sufficient concentrations of soluble non-heme iron to support normal metabolism and effective
management of non-heme iron by binding proteins to minimize oxidative stress (see Hare et al.,
2013 for a review).
In an unbound state, accumulated non-heme iron is free to aggressively react within the
cytosol and thus promotes oxidative stress (see Zecca et al., 2004; Moos and Morgan, 2004;
Mills et al., 2010; Hare et al., 2013 for reviews). Recent evidence suggests that cellular increase
in non-heme iron follows aberrant transport and storage mechanisms (Singh et al., 2009; Zhang
et al., 2009; Bartzokis et al., 2010), which become insufficient to manage the toxic
concentrations. The failure of iron concentration control has been linked to multiple factors,
including aberrations of dopamine and serotonin metabolism (Berg et al., 2007), mutations in
mitochondrial and nuclear DNA (Hamilton et al., 2001), inflammation and accelerated apoptosis
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(Zhang et al., 2009), and abnormal mitochondrial function (Mallikarjun et al., 2014). (See
Figure 2 for an illustration of aberrant iron metabolism in neuronal aging.)

These

microstructural changes have been hypothesized to affect the progressive global declines in
aging (see Raz, 2005 for a review); however, the cause of these changes is uncertain. It is
plausible that the accumulation of non-heme iron is both a cause and an effect of increased
production of reactive oxygen species and the ensuing oxidative stress (see Cherubini et al.,
2009).

Figure 2. Aberrations of iron metabolism that precipitates oxidative stress and neuronal
dysfunction in aging. The figure is constructed from evidence reviewed in Mills et al., 2010;
Zecca et al., 2004; and Chrichton and Ward, 1992.
1.2 Iron Promotes Regional Atrophy in Aging
Cellular damage associated with non-heme iron accumulation may explain many of the
cumulative structural changes observed in aging and neurodegenerative disease (Hallervorden
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and Spatz, 1922; Harman, 1956; Bartzokis et al., 1994, 1997, 1999). Several studies have noted
high concentrations of iron in Alzheimer’s disease co-localized with tangles (House et al., 2004),
plaques (Quintana et al., 2006) and amyloid burden (Rival et al., 2009).

Some have

hypothesized that oxidative stress from toxic concentrations of free iron is a primary cause of
demyelination in normal aging and exacerbation of such in Alzheimer’s disease (Bartzokis,
2011).

In healthy aging, iron concentration in brain tissue is regionally specific and the

magnitude of age differences therein vary across the affected regions (Drayer, 1988).
Subcortical regions have higher concentrations of non-heme iron relative to subcortical
white matter and the cerebral cortex. The basal ganglia have particularly large concentrations of
iron, which are relatively low in childhood and early adulthood but appear to increase in the
brains of middle-aged and older adults (Hallgren and Sourander, 1956; Thomas et al., 1993;
Bartzokis et al., 1994; Martin, Ye, and Allen, 1998; Harder et al., 2008; Siemonsen et al., 2008;
Xu et al., 2008; Aquino et al., 2009; Pfefferbaum et al., 2009, 2010; Haacke et al., 2010; Bilgic
et al., 2011; Kumar et al., 2011). A recent meta-analysis of cross-sectional magnetic resonance
imaging (MRI) studies identified age-related differences in iron content within the basal ganglia,
with the globus pallidus evidencing modestly higher content in older brains and striatum
showing a larger age-related increase (Daugherty and Raz, 2013). The accumulation of iron in
the caudate and putamen may explain to some extent their significantly smaller volumes in
advanced age (volumetric correlation with age r = -0.30 and -0.43, respectively; Raz, 2004), and
longitudinal change as well as significant individual differences therein (Raz et al., 2005; Raz et
al., 2010). Similarly, age differences in hippocampal volume (Raz et al., 2004, 2005, 2010) may
be associated with moderate increase in iron content (Rodrigue, Daugherty, Haacke, Raz, 2013).
For the lack of longitudinal investigations, these conjectures remain untested.
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Absent of disease, non-linear lifespan increases in particular brain regions may reflect
early-life concentrations, as the basal ganglia have persistently larger concentrations throughout
development compared to the rest of the brain (Thomas et al., 1993). A single longitudinal study
supports an increase in striatal iron in healthy adults within two years (Walsh et al., 2014).
However, it did not adequately account for the possible relationship between early life values
and later accumulation. Amongst other limitations, this study was in a small sample and was a
simple effects analysis of change in iron only.

Therefore, additional longitudinal study is

warranted to understand the change in brain iron in the context of change in other neural and
health correlates of age.
1.3 Cardiovascular Risk Factors Exacerbate the Increase in Iron Content and Structural
Shrinkage
Non-linear patterns of specific regional changes across the adult lifespan and individual
differences therein (Raz et al., 2004, 2005; Raz, 2005) suggest potential mediating factors
between neural and cognitive systems. The cluster of common cardiovascular risk factors (i.e.,
hypertension or high-normal blood pressure, elevated blood glucose and triglycerides, and
decreased high-density lipoprotein) has been termed metabolic syndrome (Grundy et al., 2005).
Metabolic syndrome (MetS) increases the risk for a cardiovascular event and even subclinical
elevation in these factors exacerbates neural and cognitive differences in aging to partially
explain individual differences (Dahle, Jacobs, Raz, 2009; Head et al., 2002; Raz et al., 2005).
Symptoms of MetS are also associated with greater regional iron content (Jehn, Clark, and
Guallar, 2004; Fernandez-Real, Lopez-Bernejo, and Ricart, 2005; Ascherio et al., 1994; Alissa et
al., 2007; Raz, Rodrigue, and Haacke, 2007) and oxidative stress (Berry et al., 2001). Further,
increased brain iron is observed in patients with cerebrovascular disease (Hirai et al., 1996) and
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diabetes (Rajpathak et al., 2009; Shi et al., 2006).
The links between brain iron content and MetS are unclear and likely reflect multiple
phenomena. For instance, iron may contribute to MetS through the promotion of inflammation
via oxidative stress. Indeed, greater concentrations of non-heme iron increase inflammation
(Joseph et al., 2005) and accelerate apoptosis (Zecca et al., 2004; Zhang et al., 2009). However,
it is unclear if increased iron is a cause of MetS, or if concentrations are effected by elevations in
cardiovascular risk factors. Iron is systemically delivered via vascular supply (Mills et al., 2010)
and it is plausible that regional differences in iron concentration are due to differential sensitivity
to risk factors. Non-heme iron concentrations may interact with other metabolic factors similarly
delivered, including oxygen (Mills et al., 2010; Raz, 2005) that is necessary in the production of
free radicals that promote oxidative stress. Thus, individual differences in cardiovascular risk
factors may account for differential regional changes in iron concentration and subsequent
volumetric shrinkage.

Due to the lack of longitudinal studies, the mutual effects of

cardiovascular health and brain iron in healthy human aging remain confounded. Therefore, it is
unknown whether disruption of cellular iron homeostasis underlies age-related cognitive changes
on its own or via regional brain shrinkage (see Mills et al., 2010 and Bartzokis, 2011 for
reviews).
1.4 Interaction of Iron Concentration, Regional Shrinkage and Cardiovascular Health to
Explain Cognitive Decline
Iron accumulation with age may cause cognitive declines through structural or functional
(e.g., altered neurotransmission) damage that can be traced to oxidative stress. This potential
relationship with cognitive function is poorly understood for the lack of study in healthy human
aging.

In the extant cross-sectional studies in healthy adults, increased iron content in
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subcortical structures was associated with poorer memory performance (Bartzokis et al., 2011;
Rodrigue, Haacke, and Raz, 2011; Rodrigue, Daugherty, Haacke, and Raz, 2012) and slow motor
response (Pujol et al., 1992). Elevated concentrations of brain iron have also been correlated
with cognitive deficits in Alzheimer’s disease (Qin et al., 2011; Ding et al., 2009), dementia
(Rombouts et al., 2007) and multiple sclerosis (Brass et al., 2006). In a healthy lifespan sample,
increased iron content in the basal ganglia (but not hippocampus) was associated with poorer
spatial navigation skills, and partly explained age-related deficits therein (Daugherty, master’s
thesis).

In another lifespan sample, increased hippocampal iron correlated with smaller

hippocampal volumes, and both factors explained poorer memory function with age (Rodrigue,
Daugherty, Haacke, and Raz, 2012). However, in these healthy lifespan samples, subclinical
variation in MetS factors did not account for individual variability in regional iron concentration
or volume (Daugherty, master’s thesis; Rodrigue, Daugherty, Haacke, and Raz, 2012).
Cross-sectional comparisons may minimize individual differences in cardiovascular
health and underestimate consequent effects in regional volumetry and cognitive function.
Cross-sectional studies are inherently incapable of providing valid estimates of individual
differences in change (Maxwell and Cole, 2007; Lindenberger et al., 2011; Raz and
Lindenberger, 2011). Longitudinal study is necessary to identify the role of iron in human neural
and cognitive aging. If age-related decline depends upon the accumulation of non-heme iron,
then individual differences in this factor should account for the individual differences in
longitudinal decline trajectory (see Underwood, 1975).

Therefore, the present study will

estimate regional iron content and volume in vivo within two independent, healthy adult samples
with concurrent longitudinal measurements of cardiovascular health and cognitive function.
1.5 Review of in vivo Iron Estimation: T2* Relaxometry
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Evaluation of the effects of iron on age-related changes in brain and cognition depends on
in vivo estimates of brain iron content, and MRI is well suited to obtain such measures. When
exposed to a magnetic field, the magnetic particles in the brain are excited and the phase of their
precession changes in proportion to their unique susceptibility. MRI methods of iron estimation
measure the time required for the transverse excitation to dissipate and the particles to recover
their pre-excitation phase. The addition of the susceptibility component (R2’) to the transverse
relaxation rate (R2) produces a more general relaxation rate index, R2*, with R2*=R2+R2’. The
inverse index, T2*=1/R2* is frequently used to describe the total transverse relaxation process,
and short T2* relaxation times are proportional to larger iron concentrations (Thomas et al.,
1993). On T2*-weighted images, iron-rich regions appear dark and differences in iron content
can be measured by relative differences in image intensity values.
Although T2* offers a robust in vivo measure of brain iron, it is not without limitations.
The primary confound of T2* is the contribution of myelin to transverse relaxation time
(Fukunaga et al., 2010; Langkammer et al., 2012; Lodygensky et al., 2012) that can be
misinterpreted as a difference in iron content. Thus, in deep white matter regions and areas with
myelinated fibers, T2* estimates lack specificity (see Hasan et al., 2008, 2009). Field-dependent
rate increase (FDRI), another MRI method of iron measurement, is deemed independent of this
bias (Bartzokis et al., 2007). In a recent meta-analysis, age-related differences in the basal
ganglia estimated from T2* agreed highly with FDRI-based estimates (Daugherty and Raz,
2013). Thus, T2* may be negligibly influenced by the small myelinated fibers in the striatum
(Xiang et al., 2005) and can be considered a valid estimate of iron content in subcortical
structures.

Although age differences in T2* may be further confounded by comorbid

calcification that affects the index in the same manner as iron does (Naderi et al., 1993).
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However, the influence of calcium deposits can be separately estimated only with phase imaging
and the effect of calcium on T2* is probably small in healthy aging (Haacke et al., 2005).
A problematic aspect of T2*-based and other in vivo iron estimation methods is that these
methods cannot readily distinguish between heme and non-heme iron sources. The pathological
role of iron in aging appears specific to non-heme and not heme iron, which is present wherever
cerebral blood flows (arteries and veins) or accumulates (i.e., cerebral bleed or hematoma). MRI
relaxation times are affected by both sources of iron in a similar fashion. The transverse
relaxation component of T2* (T2) correlates with regional cerebral blood volume (Anderson et
al., 2005) and susceptibility-specific T2’ decreases with age in relation to physiological changes
in blood oxygenation and vascular health (Wagner et al., 2012). A meta-analysis of in vivo MRI
studies suggests that although T2* encompasses the T2 relaxation component, estimates of agedifferences in iron content derived from T2 and T2* within subcortical regions are equivalent
(Daugherty and Raz, 2013). Thus the effect of cerebral blood volume on iron estimates in these
structures may be negligible. To further reduce the likelihood of misinterpreting cerebral blood
as non-heme iron, manual tracing on high-resolution images can exclude major vessels. Despite
limitations (Gomori and Grossman, 1993; Schenck, 1995; Schenker et al., 1993; Vymazal et al.,
1995a, 1995b), T2*-based in vivo measures of brain iron have been validated against postmortem data and phantom measurements across several brain regions (Antonini et al., 1993;
Bizzi et al., 1990; Peran et al., 2007, 2009; Pujol et al., 1992; Brass et al., 2006; Thomas et al.,
1993; Bartzokis et al., 1994).
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CHAPTER II
RESEARCH DESIGN
Specific Aim 1. Determine the change in iron content across brain regions and establish its
association with regional shrinkage of brain tissue in healthy aging.
1.1 Rationale.

Regional iron accumulation is suggested to influence volumetric

shrinkage via oxidative stress and related apoptosis. Cross-sectional studies show larger brain
iron concentrations in later life that differentiate across regions (Daugherty and Raz, 2013;
Hallgren and Sourander, 1956). Structures that are vulnerable to large age-related volume
reductions are also those shown to have high iron concentrations in later life. The basal ganglia
have markedly high early-adulthood concentrations that appear to increase with age (Daugherty
and Raz, 2013), and the caudate and putamen have demonstrably large volumetric differences in
later life (Raz et al., 2005; 2010). The hippocampus also evidences increased iron content and
volumetric decline across the lifespan (Rodrigue, Daugherty, Haacke, and Raz, 2012).
Therefore, iron content and volume will be estimated in vivo within these regions of interest
(ROIs).
As a control region, iron and volumes of the lamina quadrigemina will also be measured.
The lamina quadrigemina are composed of the inferior (auditory pathway) and superior (visual
pathway) colliquli and have not been studied in human aging. However, in rodents, equivalent
nuclei have low iron concentrations (Hare et al., 2012; Hill and Switzer, 1984), and MRI
measures of iron in the lamina quadrigemina in humans appear to be unrelated to age (Daugherty
and Raz, unpublished data). Similarly, the regional volume is expected to remain stable with
age, although there are no known studies.
1.2 Methods. A single rater (A.M.D.) manually demarcated ROIs across contiguous
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slices informed by anatomical definitions. Manual demarcation is preferred over automated
methods, as it will emphasize anatomical boundaries, allow manual exclusion of vascular
objects, and reduce residual error.

Further, due to image inhomogeneity and templates

commonly based on young brains, automated sampling may reduce age-related variance.
Therefore, the rater (A.M.D.) developed anatomically-informed rules and confirmed reliability
with intra-class correlation coefficients (ICC(3); Shrout and Fleiss, 1979) exceeding 0.90.
Average T2* relaxation time was estimated for right and left hemispheres separately in each
ROI, with smaller values corresponding to larger iron content. Similarly, bilateral volumes of
each ROI were calculated from the same manual demarcation.
These regional estimates were obtained in two independent samples of healthy adults.
The first sample (N = 89, age 19-77 years at baseline) was assessed twice within approximately 2
years. In a latent change score model, change in regional volume and T2* were estimated with
age, sex, and baseline volume and baseline T2* as covariates. Change in iron content (T2*) was
postulated to precede volumetric change., and the directionality of the effects were tested with
alternative model construction. These relationships were further tested using a latent growth
curve model approach in a second lifespan sample (N = 32, age 50-76 years at baseline) that was
assessed four times across 7 years.
Specific Aim 2. Investigate the role of metabolic syndrome indicators and pro-inflammatory
biomarkers in age-related iron accumulation and volumetric decline.
2.1 Rationale. Poor cardiovascular health (i.e., MetS and inflammation) may cause
increase in iron concentration and exacerbate consequent atrophy. MetS is associated with
increased brain iron concentrations (Jehn, Clark, and Guallar, 2004; Fernandez-Real, LopezBernejo, and Ricart, 2005; Ascherio et al., 1994; Alissa et al., 2007), with even greater increase
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in cerebrovascular disease (Hirai et al., 1996) and diabetes (Rajpathak et al., 2009; Shi et al.,
2006). Absent major pathology, subclinical elevation in these factors partially accounts for
greater brain iron content in aging (Raz, Rodrigue, and Haacke, 2007) and is correlated with
increased inflammation (Joseph et al., 2005; see Zecca et al., 2004 for a review). Increase in
brain iron may follow directly from the factors subsumed under the rubric of decreased
cardiovascular health, or indirectly in interaction with other metabolic indicators that are
delivered via vascular supply along with iron.
Regional differences in iron content and subsequent volumetric shrinkage may be
explained by differential sensitivity to cardiovascular risk factors. The basal ganglia (Feekes and
Cassell, 2006) and hippocampus (Duvernoy, 1988) are highly vascularized and sensitive to
perturbations of vascular supply and to hypoxia (Pulsinelli et al., 1982; Petito and Pulsinelli,
1984; Uehara, Tabuchi and Mori, 1999; Hawker and Lang, 1990); therefore, cardiovascular risk
factors are hypothesized to exacerbate the age-related increase in iron within these regions. The
lamina quadrigemina also have dense vascularization (Duvernoy, 1999) and these regions may
also be vulnerable to cardiovascular risk; although total iron content is hypothesized to remain
low even with subclinical increase in risk factors.
2.2 Methods.

Metabolic syndrome score (MetS) was computed by combining the

measures of fasting blood glucose, total triglycerides, high-density lipoprotein cholesterol, as
well as diagnosed or observed hypertension. These cardiovascular risk indices are age-related
and have been shown to interact with volume differences (Raz, Rodrigue, and Haacke, 2007; Raz
et al., 2005). However, in our prior studies we found that subclinical elevations in these factors
did not account for cross-sectional differences in iron content (Daugherty, master’s thesis;
Rodrigue, Daugherty, Haacke, and Raz, 2012).
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Chronic inflammation is an additional cardiovascular risk factor and is postulated to
account for declines in aging and neurodegenerative disease (Mattson and Shea, 2003). Chronic
inflammation is suggested to directly influence iron concentration and apoptosis (Moos and
Morgan, 2004) and may have a more specific effect on iron-related aging than the other systemic
cardiovascular health factors.

The present study included indices of chronic inflammation

(plasma homocysteine and C-reactive protein [CRP]), as well as measures of vitamins folate and
B12 that are necessary in the one-carbon cycle that includes homocysteine metabolism.
Increased homocysteine and lower folate (markers of increased inflammation) are associated
with cross-sectional cognitive deficits, whereas decreased folate alone may be a more sensitive
measure for longitudinal differences (Kado et al., 2005). The several cardiovascular measures
were additional covariates in the latent models to explain individual differences in regional
change.
Specific Aim 3. Evaluate the indirect effects of age on cognitive decline mediated by regional
anatomical changes.
3.1 Rationale. Iron accumulation is hypothesized as a cause for progressive cognitive
declines in healthy aging mediated by decreased volumes. Cross-sectional differences in
cognitive function have been associated with increased iron content in healthy aging and
neurodegenerative disease. Longitudinal study of regional shrinkage supports differential neural
anatomical changes that mediate age-related cognitive decline (Raz and Kennedy, 2009).
Therefore, changes in regional iron content and subsequent atrophy may mediate the effects of
age on cognitive decline.

The present study modeled change in two different cognitive

functions: working memory and spatial navigation. Verbal and non-verbal working memory
measures are accepted markers of cognitive aging (Horn and Donaldson, 1980; Lindenberger et
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al., 1993; Park, 2000) and are functional correlates of the hippocampus and striatum (Packard
and Knowlton, 2002). Similarly, performance on spatial navigation tasks declines with age and
deficits in spatial navigation correlate with regional differences in the hippocampus and striatum
(Daugherty, master’s thesis; see Moffat, 2009 for a review).
3.2 Methods. Due to limitations of sample size, this hypothesis was only tested in the
larger lifespan sample with two measurement occasions. Participants completed verbal (listening
span and n-back for digits) and non-verbal (spatial recall and n-back for objects) working
memory tasks, and a spatial navigation task (virtual Morris water maze). These were added as
additional outcome variables in the latent change score model analyses.

As the lamina

quadrigemina have no known direct contributions to working memory or spatial navigation
functions, measures in these regions served as controls for model comparisons.
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CHAPTER III
GENERAL METHODS
1. Participants
There were two lifespan samples both collected as part of larger longitudinal studies of
cognitive and neural correlates of aging. The first sample (N = 89; 71% female) of healthy
adults were age 19-77 years at baseline and were measured twice within two years (average
delay = 25.07 months, SD = 2.11). The second sample (N = 32; 58% female) of healthy older
adults were age 50-76 years at baseline and were assessed four times across 7 years (average
delay between baseline and the first two follow-up assessments = 15.55 months, SD = 2.13; and
between the 2nd and 3rd follow-up M = 60.33 months, SD = 8.82). See Tables 1 and 2 for
demographic profiles of each sample.
Table 1. Demographic profile of Sample 1.
Baseline
N

Follow-up

89

89

55.18 + 12.85

57.23 + 12.83

N of Hypertensive

17

19

Education (years)

15.70 + 2.45

15.89 + 2.93

MMSE

28.99 + 1.02

28.92 + 1.00

CESD

4.14 + 4.21

4.47 + 4.26

Age (years)

Table 2. Demographic profile of Sample 2.
Baseline

1st Follow-up

2nd Follow-up

3rd Follow-up

32

32

30

21

63.54 + 9.35

64.85 + 9.33

66.06 + 9.15

71.27 + 9.31

N of Hypertensive

7

9

10

9

Education (years)

16.28 + 2.37

16.84 + 2.67

16.90 + 2.83

16.86 + 2.69

MMSE

28.69 + 1.23

28.44 + 1.16

28.73 + 1.02

28.52 + 1.33

CESD

4.16 + 4.22

3.84 + 4.14

3.53 + 3.19

3.29 + 3.90

N
Age (years)
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For both samples, participants were recruited from the greater Metro Detroit area and
were consented following the University Human Investigations Committee guidelines.
Participants were screened for neurological and cardiovascular pathology, thyroid disorder,
psychiatric disease, drug and alcohol abuse, and head injury. Participants reported right-hand
dominance (Edinburgh Handedness Questionnaire; Oldfield, 1971) and were screened for vision
and hearing problems at each assessment. For inclusion at baseline, participants scored at least
26 on the mini-mental state examination (MMSE; Folstein et al., 1975) and less than 16 on a
geriatric depression scale (CES-D; Radloff, 1977), and these measures were repeated at each
assessment.
Sample 2 was selected for cases with at least two complete longitudinal data points of the
four assessments. At the second follow-up, 2 participants were unwilling to participate, and at
the last follow-up 10 participants declined participation, 1 participant had acquired a pacemaker
and could not be scanned, and 1 participant had died of causes unrelated to cognitive status. The
cases with missing data did not differ from those with complete data in baseline age (t = -0.16, p
= 0.87) and education (t = -1.55, p = 0.13), or MMSE (all t < 1.81, p > 0.09), CESD (all t < 1.50, p > 0.14), and hypertension status (all 2 < 0.63, p > 0.43) at any measurement occasion.
Therefore, missing data were treated as missing at random and estimated with full information
maximum likelihood in Mplus (Muthén et al., 1987), which is a well-established method to
handle missing data in multi-level models (Larsen, 2011).

Further, in the course of the

longitudinal study, 9 participants developed conditions that would have been exclusionary at
baseline: 2 participants developed bladder cancer, 1 participant a thyroid colloid cyst, 5
participants a heart condition (i.e., murmur, arrhythmia), and 1 participant reported possible
binge drinking behaviors. In order to maintain the sample size, these 9 cases were kept for main
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analyses and later excluded to determine if the main effects remained the same absent of these
possible pathologies.
Finally, inclusion criteria of both samples allowed for current prescriptions of
antihypertensive medications. In Sample 1, by the 2-year follow-up 8 participants were on a
beta-blocker, another 11 on statins, and 6 on other anti-hypertensive medications. In Sample 2,
by the last assessment 2 participants were on a beta-blocker, another 6 on statins, and 8 on other
anti-hypertensive medications. Due to the low frequency of medication use in the total samples,
these variables were not included as covariates in the models.
2. T2* Relaxometry and Regional Volumetry
The multi-echo susceptibility weighted image (SWI) sequence was acquired on a 4T
Bruker Biospin scanner with Siemens interface for the first sample, and on a 1.5T Siemens
Sonata scanner for the second sample. Due to the T2* dependence on the magnet field strength,
data were measured and modeled for each sample separately.
2.1 Image Acquisition. The SWI gradient-echo sequence for each sample was acquired
with different parameters. For the first lifespan sample, the sequence consisted of 4 echoes (echo
time, TE = 7.53-30 ms with an inter-echo interval of 7.5 ms). Other acquisition parameters were
uniform across all echoes: 1 mm3 isotropic voxel; repetition time (TR) = 35 ms; flip angle (FA) =
25º; bandwidth = 200; field of view (FOV) = 256 x 208. During pre-processing, all images were
interpolated to 1 × 1 × 1.5 mm voxel size, which improved the signal-to-noise ratio. In the
second sample, 4 echoes were also collected (TE = 10-40 ms with an inter-echo interval of 10
ms), and other acquisition parameters were: 1 × 1 × 2 mm3 voxel; TR = 100 ms; FA = 30º;
bandwidth = 170; FOV = 256 x 256. Noise was manually excluded from all measurements by
applying a threshold that selectively isolated intensity values corresponding to image
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inhomogeneity.
2.2 Pre-processing and Demarcation.

All images were pre-processed in Signal

Processing in NMR (SPIN) in-house written software: http://www.mrc.wayne.edu/download.htm
. T2* maps were interpolated to common space and estimated by a maximum-likelihood fit
function for exponential decay dependent upon TE. All boundaries were manually traced by a
single rater (A.M.D) across all selected ROIs: hippocampus (Hc), caudate (Cd), globus pallidus
(GP), putamen (Pt), and the lamina quadrigemina (LQ). Boundaries were marked on the first
echo image as an anatomical reference and copied onto the T2* map. See Appendix A for a
detailed description of the tracing procedures for each ROI and Figure 3 for examples of manual
tracings. For each ROI, T2* was estimated as the average across all slices on which a given ROI
was traced. Volumes were calculated as the sum of the traced region areas multiplied by the
slice thickness, and adjusted for cranial size using the ANCOVA approach (Jack et al., 1989).
Rater reliability was confirmed for all selected ROIs with an intra-class correlation coefficient
(ICC(3); Shrout and Fleiss, 1979) exceeding 0.90 for volume and T2* in a sub-sample of 10
cases sampled twice with a delay of 2 weeks. T2* measures of iron were further validated by
comparing baseline regional values measured from the 4T data with median post-mortem iron
concentrations reported across studies (median values from Haacke et al., 2005; R2 = 0.86) and
age-based estimates after Hallgren and Sourander’s (1958) lifespan post-mortem study (R2 =
0.99; Figure 4).
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Figure 3. Example manual tracing on 4 T and 1.5 T images. Each ROI was manually traced on
an anatomical reference image (first echo) and copied to T2* maps. On the T2*-weighted
images, voxels representing high magnetic susceptibility (i.e., iron) are visualized with dark
intensity. Cd—caudate nucleus, Pt—putamen, GP—globus pallidus, Hc—hippocampus, LQ—
lamina quadrigemina.
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Figure 4. Comparison of manually obtained T2* values (baseline 4T data) with median postmortem measures reviewed in Haacke et al., 2005 and age-based estimates after Hallgren and
Sourander, 1958. Error bars represent standard error of the mean.
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3. Circulating Biomarkers of Cardiovascular Risk: Metabolic Syndrome and Pro-inflammatory
Indicators
At MRI assessments, following a 12-hour overnight fast, several blood assays were
collected from all subjects.

The first lifespan sample had blood serum measures at both

occasions, and the second sample had blood serum measures at the three longitudinal follow-up
assessments. A metabolic syndrome factor (MetS) was computed as a composite of relevant
indices (Grundy et al., 2005): blood serum high density lipoprotein cholesterol, total
triglycerides, and glucose, as well as diagnosed or observed hypertension. Inflammation
biomarkers measured in the blood samples were plasma total homocysteine (Hcy), and Creactive protein, as well as folate and vitamin B12. Blood samples were collected close to the
MRI site by venipuncture and 20 cc of whole blood were obtained in each draw. Samples were
collected in serum separator tubes, except samples for Hcy that were collected in EDTA tubes,
centrifuged to separate plasma and placed on ice. All analyses were performed at Detroit
Medical Center laboratories. Hcy was determined by fluorescence polarization immunoassay,
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and glucose and lipids enzymatically. All measures were treated as continuous in the present
analyses.
4. Cognitive Assessment
Cognitive abilities were assessed in both samples, but due to the limitations of sample
size, hypotheses pertaining to cognitive outcomes were only tested in the first lifespan sample.
At baseline and follow-up, participants completed four working memory measures (two verbal
and two non-verbal tasks) and a spatial navigation task as part of a larger battery of study.
4.1 Verbal Working Memory. The two verbal working memory measures were listening
span and an N-back task. During listening span (LSPAN; Salthouse, Mitchell, Skovronek and
Babcock, 1990), participants were required to answer simple questions about a sentence while
simultaneously remembering the last word of the sentence. Sentences were presented in blocks
of three trials, beginning with one test item per trial up to seven items per trial. An item was
correct when the participant correctly answered the item question and recalled the word in the
correct order as presented. Performance was scored as the sum total number correct across all
trials (absolute span). This index was chosen because it presents more individual variability than
simple span, but reduces chance error that is included in total span (Engle, Cantor, and Carullo,
1992). The estimated reliability of this measure is 0.90 (Salthouse, Skovronek and Babcock,
1990).
The second index was an N-back task (Dobbs and Rule, 1989; Hultsch, Hertzog, and
Dixon, 1990) for digits. A randomly-ordered string of digits was presented to the participant,
who was required to report the digit in the nth position. String lengths varied from 5 to 9 digits,
and each digit was presented for 1500 ms. A screen prompting the participant’s response
immediately followed the last digit presented in the string. Participants were required to use a
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number pad to respond. The task had three blocks of 20 trials each. In one block the participant
reported the last digit seen (n position); the next block, the digit prior to the last (n-1); and the
third block, the n-2 position. The order of block presentation was counter-balanced between
individuals and across follow-up assessments. Performance was modeled as the proportion
correct in the n-2 condition, as the other conditions are vulnerable to ceiling effects. The
estimated reliability for this task is 0.91 (Salthouse, Hancock, Meinz, and Hambrick, 1996).
4.2 Non-Verbal Working Memory. Non-verbal working memory was measured with
spatial recall and N-back tasks. The spatial recall measure was a computerized task modified
from a task described by Salthouse (1994). Task stimuli were seven target squares within a 5 × 5
matrix that were marked with solid orange coloring. The configurations of target squares were
randomly chosen, without repetition across trials. Each matrix was presented in the center of the
screen for 3000 ms. Participants were instructed to memorize the locations of the target squares,
and following the presentation, to mark the seven target squares each with an ―X‖ in a 5 × 5
matrix provided as a printed test sheet. Performance was measured as the average number of
correct recalled items across 25 trials. The estimated reliability of this task is 0.67 (Salthouse,
1994).
The second non-verbal working measure was an N-back task (Dobbs and Rule, 1989;
Hultsch, Hertzog and Dixon, 1990) with stimuli selected from Kroll and Potter non-object norms
(Kroll and Potter, 1984). Items were selected to minimally resemble real objects (mean rating =
5.89; 1—very much like a real object; 7—nothing like a real object). As in the verbal Nback
task, there were three blocks of trials with 20 trials each. Items were presented for 2000 ms in
strings varying in length from 5 to 9 items. Participants were asked to report the items in the nth,
n-1, and n-2 positions. Participants reported items using a key pad to indicate the item as shown
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on a prompt screen immediately following the last item of each string. Performance was
measured as proportion correct in the n-1 position, as the nth position is vulnerable to ceiling
effects and the n-2 to floor effects. The estimated reliability for this task is 0.88 (Salthouse,
Hancock, Meinz, and Hambrick, 1996).
4.3 Spatial Navigation. Spatial navigation was measured in a computerized virtual Morris
water maze (vMWM) task that was developed by Moffat and Resnick (2002). A detailed
description of the virtual environment and testing procedures has been previously reported
(Moffat et al., 2007). Briefly, the vMWM was presented as a circular pool within a larger room
and the perimeter was surrounded by various objects (see Figure 5). Participants moved through
the pool environment using a joystick and viewed the environment from a first-person
perspective. The task was completed by repeatedly locating a platform that was ―hidden‖, but
stationary across trials.
4.3.1 Testing procedures. Prior to placement in the vMWM pool, participants were
trained to manipulate a joystick to travel within two unique virtual environments. To introduce
the vMWM task, participants completed six practice trials in a vMWM that included a stationary
platform that alternated between being hidden and visible on successive trials. Throughout the
practice, participants were reminded that the environment remained the same and that the
platform was stationary.
The testing vMWM included unique landmark cues, and the platform location was
unique to the testing environment and was always ―hidden‖. The starting positions were in each
of the three quadrants not containing the platform and were each repeated for a total of six trials.
The search behavior was represented by changes in position recorded as a series of Cartesian
coordinates in the virtual pool at a sampling rate of 100 Hz. No time limits were imposed on the
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participants and each trial ended upon successfully locating the platform, which resulted in the
platform lifting above the water plane with an audible signal.

Figure 5. An over-head diagram of the test vMWM
environment.

4.3.2 Navigation performance and control measures. Measures of spatial navigation
included distance traveled from the start until the first platform intersection and the fractal
dimensionality of the search path.

Distance is a well-established measure of navigation

efficiency (see Moffat, 2009 for a review) and fractal dimensionality of the search path is a
proposed measure of path complexity from which we may infer qualities of an individual’s
cognitive map (Daugherty et al., 2014). Large distance traveled to the platform or high fractal
dimensionality of the search paths are interpreted as deficits in spatial navigation.

Fractal

dimension was calculated from the Cartesian coordinates output using the FractalMean function
in

Fractal

(v

5.20)

software

developed

by

Nams

(Dalhousie

University,

http://www.dal.ca/faculty/agriculture/environmental-sciences/faculty-staff/our-faculty/vilisnams/fractal.html). Fractal dimensionality was calculated by 1-slope of the function defined by
change in log(distance) and log(spatial scale), and ranges from 1 (a straight line) to 2 (a line
filling a two-dimensional plane; Nams, 2006).

See Daugherty et al., 2014 for a detailed
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description of the fractal dimension measure of path complexity. Navigation efficiency was
modeled as the distance traveled on trials 1-3, 5, and 6 (omitting trial 4); and navigation
complexity was measured as fractal dimensionality of trials 1-4 and 6 (omitting trial 5). Only 5
trials were used for each construct due to the inconsistency of the omitted trials with the overall
learning curves in the whole sample.
Two control measures were used to assess possible age- and sex-related differences in
proficiency with the joystick and prior experience with 3D virtual environments (e.g., video
games). Following the place-navigation trials, the task was repeated in the same environment
with a visible platform. Participants were instructed to move towards the visible platform as
quickly as possible, and distance traveled was a measure of joystick control. In addition, based
on a 7-point Likert rating (1—Never; 7—Every day), participants reported how often they played
video games that displayed a 3D environment.
5. Longitudinal Structural Equation Modeling
Hypotheses were tested with longitudinal structural equation modeling: latent change
score (LCSM; McArdle and Hamagami, 2001) and latent growth curve (LGCM; Preacher et al.,
2008) models. Both modeling techniques incorporate an independent estimation of measurement
error, a robust measurement of true longitudinal change and individual differences therein, and
the incorporation of multiple variables. Latent models were estimated in Mplus (version 5.1,
Muthén and Muthén, 2008). Prior to constructing latent variable models, univariate outliers in
memory, blood assays, and anatomical measures were winsorized. All data were normed to
baseline measures for the purpose of the analyses. To avoid spurious results related to limited
sample size, simple effects models and indirect effects were bootstrapped with bias correction
(5000 iterations of the whole sample; Hayes and Scharkow, 2013) to estimate 95% confidence
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intervals (CI). Simple effects models estimated longitudinal change in a single factor without
covariates. To test hypotheses of change in one factor preceding change in another, simple
effects models were combined as parallel process models. Covariates were added to simple
effect and parallel process models of regions that demonstrated significant variance in change.
Nominal significance level was set at p = 0.05 and Bonferroni correction was used to adjust for
multiple comparisons (Bonferroni ’).
Nested models were constructed to estimate the hypothesized indirect and direct
associations between regional T2*, volumetry, and cognitive functions with age, sex,
cardiovascular risk and interactions therein as covariates.

See Table 3 for a list of latent

constructs and respective measures for identification. The indirect effect of change in iron on
decline in cognition through regional shrinkage was tested according to the James and Brett
(1984) method, in which a significant effect is sufficient to support an indirect relationship via
the specified intermediate variable(s). Model fit was determined by accepted indices (Raykov
and Marcoulides, 2006): normal theory weighted chi-square statistic (a non-significant value
indicates good fit); the proportion of chi-square to degrees of freedom (less than 2 indicates good
fit); root mean square error of approximation (RMSEA, a value equal to or less than 0.05
indicates excellent fit); comparative fit and Tucker-Lewis fit indices (CFI and TLI, respectively,
values exceeding 0.90 indicate excellent fit); standardized root mean residual (SRMR, less than
0.05 supports good fit); and Akaike information criterion (AIC, comparatively smaller values
indicate improved model fit). See Appendix C for examples of latent model construction.
5.2 Reverse Effects Models
To confirm the directionality of effects—i.e., the precedence of iron accumulation before
volumetric shrinkage and subsequent cognitive decline—the structural regression pathways were
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reversed. Due to the limitations of observational data without temporal precedence, causality
between latent constructs cannot be confirmed. Yet, latent modeling techniques are confirmatory
in nature, and regression structural pathways are unidirectional and imply causality. With the
limitation to interpretation, the directionality of an association can be confirmed by testing a
model that reverses the hypothesized relationship between variables. If the reverse effects
models fit worse than the hypothesized models, then the directionality of the effects can be
interpreted with greater confidence.
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Table 3. Latent constructs and measures for identification in analyses.
Latent Construct
Regional Iron Content
1. Caudate Nucleus
2. Putamen
3. Globus Pallidus
4. Hippocampus
5. Lamina Quadrigemina

Measure (indicator)
Left & Right T2*
Left & Right T2*
Left & Right T2*
Left & Right T2*
Left & Right T2*

Regional Volumetry
1. Caudate Nucleus
2. Putamen
3. Globus Pallidus
4. Hippocampus
5. Lamina Quadrigemina

Left & Right volume
Left & Right volume
Left & Right volume
Left & Right volume
Left & Right volume

Metabolic Syndrome

Fasting blood glucose
Total triglycerides
High density lipoprotein cholesterol
Hypertension status

Inflammation

Plasma homocysteine
C-reactive protein
Folate
B12

Cognition
1. Verbal Working Memory

Listening span
N-back for digits
2. Non-Verbal Working Memory Spatial recall
N-back for objects
3. Spatial Navigation Efficiency
5 trials, Distance
4. Spatial Navigation Complexity 5 trials, Fractal dimension of search path
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CHAPTER IV
RESULTS
1. Accumulation of Iron and Decline in Volume (Aim 1)
1.1 Sample 1 (two occasions). Change in regional iron and volume were initially tested in
simple effects latent change score models, without covariates. All simple effects models had
excellent fit according to multiple goodness-of-fit indices: 2 < 11.15, p > 0.13; RMSEA < 0.08;
CFI > 0.98; SRMR < 0.08. Iron content significantly increased in all regions (see Table 3),
except for the Hc (mean change = 0.14, p = 0.19) and the effect in the LQ did not pass criteria
for multiple comparison correction (mean change = -0.26, p = 0.03; ’ = 0.01). The magnitude
of change did not differ among regions that evidenced change in iron content (all p > 0.34).
Despite the observed mean change, the rank order of regions by their average iron content
remained the same: the GP had the most iron, followed by the Pt and Cd, and notably less iron in
the Hc and LQ (all p < 0.001; see Figure 6).

Figure 6. Sample 1 regional average T2* at baseline and at 2-year follow-up. Error bars
represent standard error of the mean; * p < 0.01.
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All regions, except the GP and LQ, significantly declined in volume, whereas LQ
evidenced volume increase (see Table 4). Significant individual differences in the regional iron
content and volume of the striatum and Hc (variance in change > 0.39, all p < 0.01) justified
further analyses seeking factors that account for the observed variability. Therefore, additional
latent change score models tested whether the increase in iron content preceded decline in
regional volume. The models included baseline age, MetS and inflammation biomarkers as
covariates.

Table 4. Sample 1: Two-year mean change and variance in change in regional iron and volume.
Mean
95% CI
Variance in
Variance in
ROI
Caudate

Globus Pallidus

Measure

Change

Mean Change

d

Change

Intercept

T2*

-0.26 *

-0.38/-0.16

-0.29

0.39 *

0.80 *

Volume

-0.51 *

-0.64/-0.40

-0.55

0.62 *

0.85 *

T2*

-0.33 *

-0.43/-0.22

-0.38

0.60 *

0.76 *

0.11

0.002/0.23

0.13

0.27 †

0.75 *

T2*

-0.33 *

-0.45/-0.20

-0.36

0.53 *

0.82 *

Volume

-0.64 *

-0.76/-0.51

-0.74

0.67 *

0.75 *

0.14

-0.05/0.32

0.17

0.99 *

0.66 *

Volume

-0.70 *

-0.81/-0.60

-0.90

0.36 *

0.61 *

T2*

-0.26 †

-0.44/-0.07

-0.28

0.99 *

0.86 *

Volume
Putamen

Hippocampus

T2*

Lamina
Quadrigemina

Volume

0.53 *

0.38/0.67

0.64

0.32

†

0.68 *

Note: Unstandardized coefficients are reported for data normed to baseline. 95% confidence
intervals are bootstrapped with bias-correction. d is an effect size estimation of mean change
calculated = Mean Change /(Variance in Intercept). * p < 0.01; † nominal p < 0.05 that does not
maintain significance after correction for multiples comparisons.

1.2 Sample 2 (four occasions). A similar pattern of effects was observed in the second
lifespan sample with four longitudinal measurements across 7 years. All simple effects models
had good fit according to multiple goodness-of-fit indices: 2 < 44.13, p > 0.08; RMSEA < 0.12;
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CFI > 0.90; SRMR < 0.14. Iron significantly increased in the GP (mean change = -0.15, p <
0.001). However, the effect in the Pt failed to maintain significance after Bonferroni correction
(mean change = -0.12, p = 0.04; ’ = 0.01), and there was no significant change in the Cd (see
Table 5). Although iron did not significantly change in these regions, volumes did shrink (all p <
0.01) to suggest an increase in relative concentration. As observed in the first sample, Hc
volume decreased (mean change = -0.65, p < 0.001), but iron content remained unchanged (mean
change = -0.14, p = 0.49).

Table 5. Sample 2: Seven-year mean change and variance in change in regional iron content and
volume.

ROI
Caudate

Measure
T2*
Volume

Putamen

Globus Pallidus

Hippocampus

Mean

95% CI

Change

Mean Change

0.07
-0.69 *
†

Variance

Variance in

d

in Change

Intercept

-0.03/0.07

0.11

0.03

0.40 †

-0.90/-0.49

-0.70

0.06 †

0.98 *

-0.21/-0.03

-0.12

0.07 *

1.00 *

T2*

-0.12

Volume

-0.40 *

-0.50/-0.29

-0.38

0.06 *

1.13 *

T2*

-0.15 *

-0.26/-0.03

-0.20

0.04

0.54

Volume

-0.37 *

-0.51/-0.24

-0.59

0.07

0.40

-0.14

-0.38/0.11

-0.12

0.49 *

1.42 *

-0.65 *

-0.71/-0.59

-1.30

0.02 †

0.25 *

0.15

-0.01/0.31

0.12

0.14 *

1.48 *

-0.44 *

-0.59/-0.30

-0.51

0.04

0.75

T2*
Volume

Lamina
Quadrigemina

T2*
Volume

Note: Unstandardized coefficients are reported for data normed to baseline. 95% confidence
intervals are bootstrapped with bias-correction. d is an effect size estimation of mean change
calculated = Mean Change /(Variance in Intercept). * p < 0.01; † nominal p < 0.05 that does not
maintain significance after correction for multiples comparisons.
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2. Accumulation of Iron Was Associated with Decline in Volume (Aim 1)
2.1 Sample 1 (two occasions). Models including change in striatal and Hc iron content,
volume, and cardiovascular risk covariates fit well: all 2 < 359.09, p > 0.22; RMSEA < 0.03;
CFI > 0.89; WRMR < 0.83. Accumulation of iron was associated with volumetric decline only
in the striatum: Cd ( = 0.49, p = 0.002; ’ = 0.02) and Pt ( = 0.31, p = 0.003; Bonferroni ’ =
0.01). Smaller baseline volumes were associated with slower shrinkage in Cd ( = -0.91, p <
0.001; ’ = 0.02) and Pt ( = -0.87, p < 0.001; ’ = 0.02). A similar effect was noted in iron
content estimates: greater iron content at baseline was associated with slower accumulation in
the Cd ( = -0.45, p < 0.05) and the effect in the Pt ( = -0.13, p = 0.05) showed a nonsignificant trend in the same direction.
Advanced age was associated with more Cd iron (r = -0.56, p < 0.001; ’ = 0.02) and
smaller volume (r = -0.28, p = 0.02; ’ = 0.02) at baseline. Similarly, at baseline older adults
had more Pt iron (r = -0.33, p = 0.003; ’ = 0.02) and smaller Pt volumes (r = -0.26, p = 0.03),
although the later effect did not maintain significance after Bonferroni correction (’ = 0.02).
The association between baseline age and striatum iron content was larger than that between age
and striatum volumes (Steiger Z = 7.17 and 3.95, p < 0.001, for Cd and Pt, respectively). Taken
together, the accumulation of iron in the striatum accounted for age-related volumetric decline
and the change in both factors was attenuated in later life. Further, there was an indirect
association between baseline iron content and change in volume in the Pt (standardized indirect
effect = -0.27, p = 0.01; ’ = 0.02; 95% CI: -0.49/-0.04) and a trend in the Cd (standardized
indirect effect = -0.22, p = 0.07; 95% CI: -0.39/-0.12), although the bootstrapped 95%
confidence intervals suggest that the test of the latter effect was under-powered. Thus, high
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baseline iron content in these regions predicted later volumetric decline. See Figure 7 for
individual change trajectories in striatal volumes and T2*.
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Figure 7. Sample 1 individual trajectories of two-year change in striatal volume and iron across
the lifespan. Gray circles represent data points that were winsorized.

In contrast to the striatum, baseline iron content in the Hc was unrelated to shrinkage. Hc
iron did not change and individual differences in Hc iron content were associated neither with
volume at baseline (r = -0.02, p = 0.83) nor with Hc shrinkage over time ( = 0.11, p = 0.41).
Advanced age was associated with greater iron content in the Hc at baseline (r = -0.26, p = 0.02;
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’ = 0.02), but not with the baseline volume (r = -0.09, p = 0.34). Similar to the striatum, the
initial (baseline) values limited subsequent decline in the Hc. Larger Hc iron content (r = -0.41,
p = 0.02; ’ = 0.02) and smaller volume (r = -0.37, p = 0.01; ’ = 0.02) limited the degree of
change in each of these factors. Therefore, individual differences at baseline partially accounted
for variability in change over time.
For the sole purpose of a control comparison, the LQ model was estimated and had
poorer fit than models of the other regions: 2 = 0.83, p = 0.17; RMSEA = 0.03; CFI = 0.83;
WRMR = 0.87. LQ iron was unrelated to volume at baseline (r = 0.01, p = 0.84) and did not
account for change in volume across time ( = -0.17, p = 0.15). Further, age was not associated
with either factor at baseline (r = -0.16 and -0.14, p > 0.15, iron and volume, respectively).
Finally, sex did not account for individual differences in striatal or Hc regional measures (all p >
0.06; ’ = 0.02).
2.2 Sample 2 (four occasions). The association between baseline values and subsequent
change was replicated in the second sample. Larger volume at baseline in the Pt (r = -0.25, p =
0.01; ’ = 0.01), Hc (r = -0.06, p = 0.002; ’ = 0.01), and a trend in the Cd (r = -0.21, p = 0.05)
was associated with greater longitudinal declines; but the same effect was not observed in the GP
(r = -0.14, p = 0.17) or LQ (r = -0.15, p = 0.38). The limiting effect of baseline on iron
accumulation in the Pt was marginally significant (r = -0.11, p = 0.05), but not in the GP (r = 0.07, p = 0.44). See figures 8 and 9 for individual change trajectories in GP and Pt iron and
volumes. Removal of the 9 participants who had developed exclusionary conditions in the
course of the study did not change the original significant effects (all p < 0.01). The precedence
of iron accumulation on volumetric shrinkage was not tested in the second sample, as no region
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demonstrated simultaneous change in iron and volume, with significant variance in volumetric
change.
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Figure 8. Sample 2: individual trajectories of seven-year change in globus pallidus volume and
iron across the lifespan. Gray circles represent data points that were winsorized.
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Figure 9. Sample 2: individual trajectories of seven-year change in putamen volume and iron
across the lifespan. Gray circles represent data points that were winsorized.
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3. Increased Cardiovascular Risk was Associated with Greater Iron Content at Baseline (Aim 2)
Cardiovascular risk was modeled as two latent factors: MetS and inflammation. Neither
factor significantly changed longitudinally in either sample (all p > 0.10). Therefore, each factor
was modeled as time invariant.
3.1 Sample 1 (two occasions). Higher MetS factor score was associated with greater
baseline iron content in the Cd ( = -0.33, p = 0.003; ’ = 0.02), and the effect in the Pt did not
meet criteria for multiple comparison correction ( = -0.25, p = 0.04; ’ = 0.02). Independent of
the regional iron content, higher MetS score was associated with smaller baseline Pt volume (r =
-0.23, p = 0.01; ’ = 0.02) but not Cd volume (r = -0.09, p = 0.31). As was previously described,
differences at baseline were associated with variability in change. An increase in MetS score
correlated with greater iron content and smaller volume in the striatum at baseline, which
independently accounted for attenuated decline over time. However, the indirect associations
between baseline MetS score and change in regional iron content and volume were not
significant (all p > 0.10). Therefore, MetS risk explained individual differences in the striatum at
baseline, but did not independently account for individual differences in change.
Metabolic syndrome score was unrelated to measures of the Hc (all p > 0.55). Elevation
in MetS score correlated with higher baseline iron in the LQ (r = -0.33, p = 0.02), but not with
other measures in that region (all p > 0.38). Inflammation score was unrelated to iron content or
volumes in any region (all p > 0.24). Advanced age was associated with higher MetS score
(4.63, p = 0.002) and men had a higher score (-0.29, p = 0.01). But age (-0.81, p = 0.35) and sex
(-0.07, p = 0.24) were unrelated to inflammation scores.
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3.2 Sample 2 (four occasions). In the second sample, neither metabolic syndrome nor
inflammation accounted for individual differences in Pt or Hc iron (all  < 2.41, all p > 0.58) or
volume (all  < -0.42, all p > 0.71).
4.Less Improvement in Working Memory was Associated with Regional Iron and Volume (Aim 3)
Working memory was assessed in verbal and non-verbal domains in Sample 1. Simple
effects models for change in working memory fit very well: all 2 < 6.53, p > 0.37; RMSEA <
0.03; CFI = 1.00; SRMR < 0.07. Non-verbal working memory did not change (mean change =
-0.02, p = 0.76; 95% CI: -0.10/0.07), nor was there significant variability in change ( = 0.01, p
= 0.85). Therefore, this construct was not considered in the remainder of the analyses.
Verbal working memory significantly improved after the two-year delay (mean change =
0.23, p < 0.001; 95% CI: 0.14/0.34), and individuals varied in verbal working memory at
baseline ( = 0.46, p = 0.004), but not in the magnitude of change ( = 0.05, p = 0.49). Poorer
verbal working memory at baseline was associated with advanced age ( = -0.76, p < 0.001),
and, marginally, with smaller Cd volume ( = 0.18, p = 0.05). Declines in Cd and Hc volumes
were associated with lesser improvement in verbal working memory:  = -0.32, p = 0.02;  = 0.34, p = 0.01, respectively (Figure 10). Cd ( = 0.21, p = 0.17) and Hc ( = 0.11, p = 0.56) iron
content was unrelated to baseline performance. The indirect effect of baseline Cd iron on change
in verbal working memory failed to reach significance (standardized indirect effect = -0.35, p =
0.06). Thus, accumulation of iron accounted for regional volumetric shrinkage, but did not
independently explain change in verbal working memory.
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Figure 10. Simplified parallel process latent change score models of Cd and Hc iron and volume
effects on verbal working memory.  indicates latent change; MetS—metabolic syndrome
factor, Vol—volume, VWM—verbal working memory.
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5. Decline in Spatial Navigation Efficiency was Associated with Increased Iron, not Shrinkage
(Aim 3)
Learning slopes in vMWM navigation were measured as navigation complexity and
navigation efficiency in Sample 1. The models examined change in learning slopes across 5
repeated trials comparing baseline to the 2-year follow-up, while controlling for potential
individual differences in the first trial.

The simple effects models for spatial navigation

complexity and efficiency had excellent fit: all 2 < 39.66, p > 0.27; RMSEA < 0.04; CFI > 0.95;
SRMR < 0.09. The learning slopes of navigation complexity, or fractal dimensionality of the
search paths, did not change (mean change = 0.12, p = 0.38; 95% CI: -0.10/0.36), nor were there
significant individual differences in change ( = 0.16, p = 0.14). Learning slopes in navigation
efficiency, or distance traveled from the start to the platform, did change (mean change = 0.21, p
= 0.04; 95% CI: 0.07/0.48). Examination of the 95% confidence intervals suggests individual
differences in baseline learning ( = 0.03, p = 0.24; 95% CI: 0.002/0.13), and marginal
individual differences in change over time ( = 0.03, p = 0.31; 95% CI: 0.00/0.17). Therefore,
additional models were estimated to test the contribution of regional iron content and volumes to
baseline spatial navigation efficiency and subsequent change.
Parallel process latent change score models that included the effects of regional iron
accumulation and volumetric shrinkage on spatial navigation efficiency, with cardiovascular risk
factors and age covariates fit well: all 2 < 530.81, p > 0.31; RMSEA < 0.02; CFI > 0.90; SRMR
< 0.89. Baseline slope was unrelated to baseline Cd iron content (r = -0.04, p = 0.11) or volume
(r = -0.03, p = 0.12), and these were constrained in the final model. There was a non-significant
trend for an association between the accumulation of iron in the Cd and lesser improvement at
follow-up ( = -0.94, p < 0.06; 95% CI: -1.91/-0.28), and examination of the bootstrapped 95%
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confidence intervals suggests that the test of this effect was under-powered in the present sample
(see Figure 11). Change in Cd volume was not related to change in vMWM performance ( =
0.09, p = 0.28). Differences in longitudinal change in Hc iron ( = -0.02, p = 0.53) and volume
( = 0.01, p = 0.88) were unrelated to longitudinal change in spatial navigation efficiency. Iron
content and volumes of other ROIs were also not significant predictors (all p > 0.25). Advanced
age was associated with less efficient performance on the first trial ( = 0.01, p < 0.001), but not
with baseline learning slope (r = 0.54, p = 0.17). MetS score, inflammation, and sex were not
independently related to spatial navigation performance (all p > 0.13), and these paths were
constrained in the final models. There were no significant age- or sex-related differences in the
vMWM control measures: joystick control (all p > 0.22) or experience with 3D video games (all
p > 0.68); and in the interest of parsimony, these variables were excluded from the latent models.
6. Reverse Effects Models
To test the directionality of effects—i.e., the precedence of iron accumulation before
volumetric shrinkage and subsequent cognitive decline—the structural regression pathways were
reversed. All reverse effects models fit worse than the hypothesized models: all 2 > 572.95, p <
0.16; RMSEA > 0.03; CFI < 0.82; SRMR > 0.91.
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Figure 11. Simplified parallel process latent change score model of Cd iron and volume effects
on spatial navigation efficiency (distance to platform).  indicates latent change; Met—
metabolic syndrome factor, Vol—volume, Dist—distance.
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CHAPTER V
DISCUSSION
More than a half-century ago, the accumulation of free non-heme iron in the brain was
proposed as a mechanism to explain neural and cognitive decline in aging and disease (Harman,
1956). The present study provides the first longitudinal evidence for iron accumulation in
normal aging. Further, regional accumulation of iron over a two-year span partially explained
volumetric shrinkage and cognitive changes—accepted hallmarks of aging.
As has been observed before, regions differed in iron content. The basal ganglia have
large concentrations of iron persistently across the lifespan. Based on post-mortem measures,
iron appears to increase exponentially in the basal ganglia during child development (Hallgren
and Sourander, 1958), and as shown here, regional iron continues to accumulate into later life.
Based on cross-sectional studies, iron was thought to preferentially increase in the striatum (see
Daugherty and Raz, 2013 for a review), but this was not observed in the patterns of longitudinal
change. Despite longitudinal increase, the rank order of regional iron content was maintained:
the GP had the largest content, followed by the striatum, and notably less in the Hc and LQ.
Regional differences in iron content may be due to metabolic demands of neural function.
For example, dopamine transmission is dependent upon non-heme iron (Berg et al., 2007), and
regions that are rich in iron express dopamine: the basal ganglia (Rice, Patel, and Crag, 2013;
Packard and Knowlton, 2002; Martin, Ye, and Allen, 1998), the red nucleus and the substantia
nigra (see Daugherty and Raz, 2013 and Zecca et al., 2004 for reviews; Packard and Knowlton,
2002). Diseases diagnosed by abnormally high iron content in these regions often present with
motor dysfunction that is also dopamine-dependent (Rice, Patel, and Crag, 2013; see Zecca et al.,
2004 for a review). Taken together, these observations suggest that non-heme iron in the brain
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supports dopaminergic function. Therefore, accumulation of iron in the basal ganglia may occur
initially to meet the metabolic demands of neural transmission (see Mills et al., 2010).
Eventually iron metabolism becomes either corrupted or insufficient to manage the large
concentrations (Hare et al., 2013), leading to an unchecked increase in free iron. An unregulated
accumulation of non-heme iron will promote oxidative stress that can disrupt neural function
(see Zecca et al., 2004; Mills et al., 2010 for reviews). Because the trajectory of change appears
to be monotonic, it is unclear at which point in the lifespan iron accumulation stops being
adaptive and instead becomes a harbinger of impairment.
In addition to disrupting neural transmission, increased iron content may cause neural
atrophy via oxidative stress.

Non-heme iron accumulation outside of ferritin sequestration

accelerates apoptosis and is a proposed mechanism to explain regional shrinkage (see Bartzokis,
2011; Mills et al., 2010 for reviews). As evidenced here, shrinkage of the striatum followed
accumulation of iron in these regions. The association between longitudinal changes in iron
content and volume was observed only in the striatum; differences in iron content were unrelated
to Hc and GP volumes. However, at baseline, high iron content in the Hc and GP was associated
with smaller volumes, similar to what has been reported in extant cross-sectional studies
(Rodrigue et al., 2012; 2011; Cherubini et al., 2009). It is plausible that iron-related shrinkage
may be observed in these regions with a longer delay than two years. Yet, in the second sample
with measurements over 7 years, there were no individual differences in GP volume shrinkage,
nor a significant change in Hc iron, and thus this hypothesis could not be further tested. The
second sample was limited to adults 50 years and older, which omitted age-related variability in
earlier adulthood; lacking this contrast, the magnitude of individual differences in later life may
be reduced. Thus, a larger lifespan sample with long delays may identify iron-related shrinkage
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in extra-striatal regions. Nonetheless, regional iron accumulation was observed in both samples,
and there were significant individual differences in change.
Individual differences in iron-related shrinkage were in part explained by increase in
cardiovascular risk factors. Elevation in MetS score was associated with increased iron content
in the striatum at baseline.

Metabolic syndrome compromises blood flow to the brain,

interrupting the delivery of necessary oxygen and metabolites (Grundy et al., 2005). A decrease
in iron metabolites that are delivered via vascular supply may lead to regional accumulation of
iron (Hare et al., 2013). In addition, the brain vascular endothelium regulates brain iron transport
(Deane et al., 2004) and a decrease in blood flow may lead to iron mired within regions,
increasing the risk to oxidative stress.

Thus, poor cardiovascular health—even subclinical

elevations in risk factors—increases the likelihood of iron-related atrophy.
Increased cardiovascular risk has been reported to exacerbate age-related brain shrinkage
(Rodrigue et al., 2011; Raz et al., 2005; Raz, 2004), but the mechanism by which this effect
occurs is unclear. Possibly, increased cardiovascular risk causes an increase in iron-related
oxidative stress to affect volume. Elevations in MetS score were associated with higher baseline
iron content, which in turn accounted for individual differences in the changes in iron and
volume. However, the MetS factor did not selectively act through iron content—higher MetS
score was independently associated with decline in Pt volume. Thus, MetS risk may be a nonspecific factor that increases vulnerability to iron-related atrophy amongst other age correlates.
Higher MetS was associated with greater risk for decline, but the rate of change in iron
and volume was limited by the baseline state. Observed in both longitudinal samples, persons
with greater iron at baseline did not accumulate as much over time compared to those with lower
levels. Similarly, smaller volumes at baseline were associated with less shrinkage over time.
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Greater iron and smaller volumes at baseline were associated with advanced age and MetS, and
this constellation of factors limited subsequent change in regional measures. In other words,
elevations in the MetS factor may increase the risk for iron-related atrophy, but decline in
healthy adults is constrained by a threshold that likely distinguishes aging from disease. Indeed,
the smaller effect sizes in the second older sample may support a non-linearity in lifespan
change. Whereas attenuated iron accumulation may be due to saturation, attenuated shrinkage
suggests neural resiliency. If interpreted as independent mechanisms, these two effects appear to
be in opposing directions. Yet, when considered together as part of a singular mechanism of
decline, staved change in either factor limits the degree of global decline.
This is incongruent with an alternative hypothesis of brain reserve in aging (Satz, 1993),
which posits that larger brain volumes would be associated with lesser decline, not greater. The
evidence for the brain reserve hypothesis has been inconsistent in studies of healthy aging (Raz
et al., 2005; 2010), but there is greater support from studies of clinical dementia and Alzheimer’s
disease (see Valenzuela, 2008; Fratiglioni and Wang, 2007 for reviews).

Thus, the

inconsistencies may be attributable to a distinction between normal aging and disease. Because
symptoms of age-related neurodegenerative disease present along a continuum that overlaps with
normal age-related declines (Walters, 2011; Petersen et al., 2011; Petersen et al., 1999), it is an
immediate research interest to distinguish healthy aging from prodromal disease. This intriguing
challenge is best aided by studies of aging selecting samples with optimal health, even excluding
relatively common age-concomitant pathologies. In such samples (e.g., Raz et al., 2010) there is
evidence for a threshold between healthy aging and disease, and absent of pathology, healthy
adults may not pass this threshold.
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In the present study, an attenuation of the rate of change in both iron and volume further
supports the hypothesis of a threshold between healthy aging and disease. Normal aging appears
to be characterized by moderate increase in iron and declines in volume. The degree of decline
may be larger in diseases such as Alzheimer’s disease (Bartzokis, 2011) or multiple sclerosis
(Walsh et al., 2014). In these diseases and aging, iron accumulation has been proposed as a
mechanism of global brain decline and related cognitive deficits (see Bartzokis, 2011; Zecca et
al., 2004 for reviews).
Here, iron accumulation was related to individual differences in longitudinal change in
cognition, namely in verbal working memory and spatial navigation. Verbal working memory
improved over time, independent of age. This is typical of memory tasks that can benefit from
repeated exposure, or retest effects (Thorvaldsson et al., 2005). However, greater accumulation
of iron in the Cd limited the degree of improvement in memory. This effect was associated with
advanced age—older adults who had more iron at baseline benefited less from retest compared to
their younger counterparts with less iron. An increase in iron was associated with a decrease in
Cd volume that in turn accounted for lesser improvement in verbal working memory; however,
the complete indirect effect was a non-significant trend.
Whereas Cd iron was indirectly associated with verbal working memory, it was directly
associated with lesser improvement in spatial navigation over time. Smaller Cd volumes have
been correlated with cross-sectional age-related deficits in vMWM navigation (Moffat et al.,
2007). However, here longitudinal iron accumulation and not volumetric shrinkage accounted
for differences in spatial navigation efficiency. The benefits of repeated testing on the vMWM
task may follow from a procedural learning component, a function that depends on neostriatal
circuits (Packard and Knowlton, 2002).

Further, in a rodent model of MWM navigation,
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interruption of striatal dopamine (see McNamara and Skelton, 1993 for a review) and induced
high concentrations of iron (Maaroufi et al., 2009a; 2009b) mimic the iron-related decline in
vMWM place navigation reported here.

Thus, subcortical iron accumulation may affect

cognitive declines either directly due to impaired neurotransmission or indirectly via oxidative
stress that promotes volumetric shrinkage. This study offers the first longitudinal evidence for a
role of iron accumulation in a nomological model of cognitive aging.
This model of aging includes other correlates of cognitive decline, such as volumetric
shrinkage in other regions. Hc volume shrinkage, but not iron accumulation, was associated with
a decreased benefit in verbal working memory retest, and not in spatial navigation. Previous
cross-sectional study had suggested a mediation effect of increased iron on memory decline
through decreased Hc volume (Rodrigue et al., 2012). This was not supported in the longitudinal
model. Although a similar cross-sectional association between age, iron, volume, and memory
was found at baseline. Cross-sectional studies provide a biased estimate of change, whereas
longitudinal study is a more accurate portrayal of the gradual aging process (Lindenberger et al.,
2011; Raz and Lindenberger, 2011).
Based on the pattern of longitudinal change reported here, regional iron accumulation
appears to precede the volumetric shrinkage and cognitive declines that are hallmarks of aging
(Raz et al., 2004; Raz, 2005; Horn and Donaldson, 1980). The accumulation of iron partially
accounted for differential associations between age and regional brain volumes that are
frequently observed (see Raz et al., 2005).

Moreover, baseline iron was associated with

subsequent volumetric shrinkage. Thus, high iron content foreshadowed later decline. The
utility of iron as a biomarker for neural decline has been suggested (Schenck and Zimmerman,
2004) but until now it had not been tested in a longitudinal study of normal aging.
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Establishing non-heme iron as a harbinger of impairment has immediate clinical
applications. Whereas other risk factors are systemic and measured peripherally, iron is localized
and can be observed directly in the brain (Thomas et al., 1993). Further, iron is easily detectable
with MRI using noninvasive methods that can be adapted for clinical diagnostic criteria. MRI
screening of iron is a current standard in the diagnosis of neurodegeneration with brain iron
accumulation—diseases that are characterized by an extreme concentration of brain iron
presenting in early life (see Zecca et al., 2004 for a review). A similar approach to identify
adults at a higher risk for declines in aging may be feasible in the future. In addition to
improving diagnostic criteria of age-related disease, early detection in normal aging may allow
for interventions to help maintain function longer into later life. The predictive validity of iron
as a biomarker for future neural and cognitive decline requires additional longitudinal study.
Study Limitations
These findings should be interpreted with consideration of the study limitations. First,
T2* is a sensitive, but not specific, measure of iron in the brain, as differences in T2* can be
caused by the accumulation of other magnetic materials (Haacke et al., 2005). For example,
calcium, which may increase in subcortical regions with age (Naderi et al., 1993), can be
distinguished from iron in MRI only with phase-based imaging (Haacke et al., 2005). Future
longitudinal studies may benefit from including several iron imaging methods to allow
potentially more sensitive and more specific measurements. Validity of T2* as an index of iron
content may be threatened by regional differences in myelination (Fukunaga et al., 2010;
Langkammer et al., 2012; Lodygensky et al., 2012). Although the influence of myelin in the
basal ganglia is likely negligible (Daugherty and Raz, 2013), the T2* measures should be
interpreted with this possible confound in mind.
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Second, the longitudinal modeling in the larger sample was limited to two measurement
occasions. Such pre-post design allows for an accurate estimation of linear change, but potential
non-linear effects are obscured (McArdle and Hamagami, 2001).

The second sample had

additional time points, but due to limitations of sample size, non-linear effects could not be
adequately tested. The several null effects in the second sample may reflect the suggested nonlinearity in lifespan change approaching a threshold between healthy aging and prodromal
disease. The selection for optimal health and limited age range of the second sample may have
further minimized the effects that would otherwise be observed in a lifespan sample of more
representative health history.
Third, the longitudinal models cannot establish causality amongst factors. The models
were constructed based on theory to test for iron accumulation preceding volumetric shrinkage
and cognitive declines. These models represented the observed data well. Animal studies of
interventions support the model of change in iron preceding volume shrinkage (e.g., Zhang et al.,
2009), but the longitudinal models presented here cannot independently establish causality.
Several longitudinal time points are necessary to test for temporal precedence and it remains
questionable to what extent observational measurements can assess causality at all (Winship and
Morgan, 1999; also see Rubin, 2005; Pearl, 2013a, 2013b).
Conclusion
In conclusion, this is the first longitudinal evidence for subcortical accumulation of iron
as a factor in cognitive aging. Regional differences in iron suggest a possible metabolic demand
that initial increase in iron may be used to meet. However, eventually the excess becomes
deleterious. As shown here, an accumulation of iron preceded volumetric shrinkage in the
striatum, but not in the Hc or GP. Individual differences in the accumulation of iron and
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volumetric shrinkage were partially accounted for by MetS. Persons with high MetS scores had
greater iron at baseline that subsequently accounted for volumetric shrinkage. Critically, large
iron content at baseline was predictive of subsequent volumetric shrinkage over two years.
Finally, increased iron and shrinkage of the Cd was associated with lesser improvement on
verbal working memory and spatial navigation tasks. Taken together, high iron content may be a
meaningful biomarker of neural and cognitive declines in normal aging.
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APPENDIX A
Longitudinal Sample Attrition
Table A1. Detailed description of Sample 1 attrition between baseline and the 2-year follow up.
Reason for Exclusion/Attrition

n

Original Sample

360

Unwilling to participate/Lost Contact

154

Screening Failures/Below Normal Hearing

18

MRI error/MRI incompatibility

83

MRI incidental findings

3

Development of exclusionary conditions at
Follow-up (medical diagnosis, CESD, MMSE)

10

Sequence was not collected

3

Retained Sample

89

Table A2. Detailed description of Sample 2 attrition across 4 time points.
1st

2nd

3rd

Baseline

Follow-up

Follow-up

Follow-up

Original Sample

91

--

--

--

Unwilling to participate/Lost Contact

56

2

10

Screening Failures/Below Normal Hearing

3

Reason for Exclusion/Attrition

MRI error/MRI incompatibility

1

MRI incidental findings

1

Development of exclusionary conditions
(medical diagnosis, CESD, MMSE)

7

9

Deceased
Retained Sample

9
1

32

32

30

21

8

9

9

Sub-sample of cases that developed
exclusionary criteria
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APPENDIX B
Detailed description of the manual tracing procedures for each region of interest.
Basal ganglia. The caudate (Cd), putamen (Pt), and globus pallidus (GP) were ranged
together. The ventral section began with the first slice on which the head of the caudate
appeared, dorsal to visualization of the substantia nigra and red nuclei. Due to the inconsistency
in image clarity, the GP and Pt could not be reliably traced ventral to the Cd. The GP ROI
included the pars medialis and lateralis as a single region. The GP and Pt were traced until no
longer visualized. The Cd ROI included only the head and body of the caudate, excluding the
tail. The Cd range terminated when the lateral thalamic nucleus was no longer visualized, at
which point the head and tail of the caudate became continuous. The three ROIs were traced on
every slice of the respective range, which was approximately eight slices for the Cd and Pt, and
five slices for the GP. The ICC(3) for total volume and average T2*, respectively, was 0.99 and
0.98 for Cd, 0.99 and 0.98 for GP, and 0.99 and 0.97 for Pt.
Hippocampus. The ROI included the head and body of the hippocampus (Hc), excluding
the fimbria-fornix; however, the image resolution was not high enough to distinguish subfields of
the hippocampus. The most ventral slice began with visualization of the superior colliculus and
red nucleus, while the cerebellar vermis were still visualized. The terminal end of the range was
marked when the head of the caudate was visualized. The Hc was traced on approximately six
contiguous slices.

The ICC(3) for total volume and average T2* were 0.99 and 0.95,

respectively.
Lamina quadrigemina. The inferior and superior colliquli were traced as a single ROI:
the lamina quadrigemina (LQ). The ventral slice was identified by the first visualization of the
inferior colliquli when the red nucleus, substantia nigra, and cerebellar vermis were still
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visualized. The ROI was traced on four contiguous slices that terminated when the superior
colliquli were no longer visualized. The ICC(3) for total volume and average T2* were both
0.98.
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APPENDIX C
Longitudinal Latent Model Construction Diagrams
Figure C1. Example simple effects latent change score models for regional volume and iron
(T2*). * indicates an estimated parameter; *= indicates an estimated parameter that was
constrained across time.
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Figure C2. Example simple effects latent change score models for verbal (VWM) and nonverbal working memory (NVWM). * indicates an estimated parameter; *= indicates an
estimated parameter that was constrained across time.
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Figure C3. Example simple effects latent change score models for metabolic syndrome (MetS)
and inflammation (Inflam). Glu—fasting glucose, HDL—high-density lipoprotein, Triglyc—
total triglycerides, HTN—diagnosed or observed hypertension, CRP—C reactive protein,
Hcsy—plasma homocysteine, Fol—folate. * indicates an estimated parameter; *= indicates an
estimated parameter that was constrained across time.
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Figure C4. Mixed latent change score model for spatial navigation distance learning slopes. *
indicates an estimated parameter; *= indicates an estimated parameter that was constrained
across time.
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Figure C5. Example of a parallel process model including change in iron, change in volume,
change in verbal working memory, and covariates * indicates an estimated parameter; *=
indicates an estimated parameter that was constrained across time.
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Figure C6. Example of a parallel process model including change in iron, change in volume,
change in spatial navigation learning slope, and covariates. * indicates an estimated parameter;
*= indicates an estimated parameter that was constrained across time.
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Figure C7. Example of a latent growth curve model for change in volume and iron (T2*). *
indicates an estimated parameter; *= indicates an estimated parameter that was constrained
across time.
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Figure C8. Example of a latent growth curve model including covariates. MetS—metabolic
syndrome; Inflam—inflammation; Glu—fasting glucose, HDL—high-density lipoprotein,
Triglyc—total triglycerides, HTN—diagnosed or observed hypertension, CRP—C reactive
protein, Hcsy—plasma homocysteine, Fol—folate.* indicates an estimated parameter; *=
indicates an estimated parameter that was constrained across time.
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ABSTRACT
ACCUMULATION OF SUBCORTICAL IRON AS A MODIFIER OF VOLUMETRIC
AND COGNITIVE DECLINE IN HEALTHY AGING: TWO LONGITUDINAL
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Degree: Doctor of Philosophy
Accumulation of non-heme iron in the brain has been theorized as a cellular mechanism
underlying global neural and cognitive decline in normal aging and neurodegenerative disease.
Relatively few studies of brain iron in normal aging exist and extant studies are almost
exclusively cross-sectional. Here, I estimated iron content via T2* and measured volumes in
several brain regions in two independent samples of healthy adults. The first sample (N = 89)
was measured twice with a two-year delay and the second sample (N = 32) was assessed four
times over a span of 7 years. Latent models estimated change in iron and volume, and the effects
of cardiovascular risk factors as modifiers of change trajectories. Iron significantly increased
(T2* decreased) over time in the basal ganglia, but not in the hippocampus. Accumulation of
iron accounted for shrinkage in the striatum. Elevated metabolic syndrome risk indicators were
associated with greater iron at baseline, which accounted for individual differences in shrinkage.
Increase in caudate iron content was associated directly with lesser improvement in virtual
Morris water maze navigation, and indirectly via shrinkage with lesser improvement in verbal
working memory. This study presents the first longitudinal evidence in support of iron as a
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biomarker of age-related decline in regional volume and cognition.
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